Sales A, Cappellozza B I, Vilela E, Claro Júnior I, Sá Filho O G, Vasconcelos J L M
Lageado Biotecnologia e Pecuária, Mineiros, GO, 75830-000, Brazil.
Chr. Hansen A/S, Hørsholm, 2970, Denmark.
Theriogenology. 2023 Oct 15;210:207-213. doi: 10.1016/j.theriogenology.2023.07.032. Epub 2023 Jul 26.
This experiment was designed to evaluate the effects of increasing doses of estradiol cypionate (ECP) and different body condition score (BCS) on reproductive performance of Bos indicus beef females assigned to a timed-artificial insemination (TAI) management. In this experiment, 1683 Bos indicus Nellore cows were blocked by parity and assigned to receive 1) an intravaginal P4 device (1.9 g of P4) and 2.0 mg of estradiol benzoate on day -11, 12.5 mg (i.m.) of dinoprost tromethamine, 300 IU (i.m.) of equine chorionic gonadotrophin, 0.6 mg (i.m.) of estradiol cypionate and CIDR withdrawal on day -2, followed by TAI on day 0 (n = 849; 0.6ECP) or 2) the same synchronization protocol with 1.0 mg of ECP on day -2 (n = 834; 1.0ECP). In both treatments, estrus expression was measured between days -2 and 0. Body condition score (BCS) was evaluated on days -11, 31, and 71 of the experiment and the BCS variation (Δ) was also determined between these timepoints. Transrectal ultrasonography was performed on days 31, 71, and 111 for pregnancy rate determination. All binary data were analyzed using cow as the experimental unit with GLIMMIX, whereas continuous variables were analyzed with the MIXED procedure of SAS. No treatment effects were observed on estrus expression rate. Treatment × BCS interactions were observed for pregnancy rates in all time points (days 31, 71, and 111), as 1.0ECP cows with a LOW BCS also had a greater P/AI than cows assigned to 0.6ECP. In summary, increasing the dose of ECP benefited the reproductive performance of Nellore beef cows with a reduced BCS (≤2.75), whereas no benefits were seen when the BCS was considered adequate (>2.75).
本实验旨在评估增加剂量的环丙孕酮(ECP)和不同体况评分(BCS)对采用定时人工授精(TAI)管理的印度瘤牛母牛繁殖性能的影响。在本实验中,1683头印度瘤牛内洛尔牛按胎次进行分组,并被分配接受以下处理:1)在第 -11天放置阴道孕酮(P4)装置(1.9克P4)和2.0毫克苯甲酸雌二醇,在第 -2天注射12.5毫克(肌肉注射)氯前列醇钠、300国际单位(肌肉注射)马绒毛膜促性腺激素、0.6毫克(肌肉注射)环丙孕酮,取出阴道孕酮装置,然后在第0天进行定时人工授精(n = 849;0.6ECP组);或2)相同的同期发情方案,但在第 -2天注射1.0毫克环丙孕酮(n = 834;1.0ECP组)。在两种处理中,均在第 -2天至第0天期间测量发情表现。在实验的第 -11天、第31天和第71天评估体况评分(BCS),并确定这些时间点之间的BCS变化(Δ)。在第31天、第71天和第111天进行经直肠超声检查以确定妊娠率。所有二元数据以母牛作为实验单位,使用GLIMMIX进行分析,而连续变量则使用SAS的MIXED过程进行分析。在发情表现率上未观察到处理效应。在所有时间点(第31天、第71天和第111天)的妊娠率上均观察到处理×BCS的交互作用,因为BCS低的1.0ECP组母牛的受胎率(P/AI)也高于0.6ECP组的母牛。总之,增加环丙孕酮的剂量有利于BCS降低(≤2.75)的内洛尔肉牛母牛的繁殖性能,而当BCS被认为充足(>2.75)时则未观察到益处。